首页>外文期刊>医学、药学、卫生>药学>Therapeutic advances in drug safety.

Therapeutic advances in drug safety.

SCIMEDLINE

中文名称：药物安全性的治疗进展。

ISSN：2042-0986
出版周期：Bimonthly

发文量：304

期刊论文

热门论文

年度选择

2021
- 第12期
- 第a期
2020
- 第12期
- 第a期
2019
- 第10期
- 第12期
2018
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2017
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2016
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2015
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2014
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2013
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2012
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2011
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2010
- 第1期
- 第2期

更多>>

全选（0）

1.Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatry

机译：鬼药的诅咒：口服控释制剂在粪便中空的完整外壳通过中的作用。与精神病学有关的两个病例报告和文献复习
- 作者：Tongeji Elifazi Tungaraza;Pravija Talapan-Manikoth;Rosemary Jenkins
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第2期
- Controlled releasedrug releaseghost pillvenlafaxineOxycontinediffusionosmotic release;
2.Pharmacogenetic testing: current evidence of clinical utility

机译：药物遗传学测试：临床实用性的最新证据
- 作者：Jivan Moaddeb;Susanne B. Haga
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第4期
- abacavirclopidogrelcodeinepharmacogeneticstestingwarfarin;
3.Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: a systematic review

机译：防止由于不良药物事件而撤回不必要的处方药的系统：系统综述
- 作者：Carolien M.J. van der Linden;Paul A.F. Jansen;René J.E. Grouls;Rob J. van Marum;Marianne A.J.W. Verberne;Lieke M.A. Aussems;Toine C.G. Egberts;Erik H.M. Korsten
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第2期
- adverse drug eventallergycomputerized physician order entryclinical decision support;
4.Selective serotonin reuptake inhibitors and torsade de pointes : new concepts and new directions derived from a systematic review of case reports

机译：选择性5-羟色胺再摄取抑制剂和尖端扭转型室速：从病例报告的系统回顾中得出的新概念和新方向
- 作者：Christopher Kogut;Ericka Breden Crouse;W. Victor R. Vieweg;Mehrul Hasnain;Adrian Baranchuk;Geneviève C. Digby;Jayanthi N. Koneru;Antony Fernandez;Anand Deshmukh;Jules C. Hancox;Ananda K. Pandurangi
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第5期
- antidepressant drugsQTc interval prolongationSSRIstorsade de pointes;
5.The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review

机译：接受卡马西平，奥卡西平或埃斯卡西平治疗的HLA-A * 31:01等位基因患者出现皮肤不良反应的风险
- 作者：Nahoko Kaniwa;Yoshiro Saito
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第6期
- BiomarkerHLA genotypehypersensitivity syndromeStevens–Johnson syndrometoxic epidermal necrolysis;
6.Methodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy

机译：使用常规收集的健康数据调查怀孕期间用药的长期影响的方法学挑战
- 作者：Luke E. Grzeskowiak;Andrew L. Gilbert;Janna L. Morrison
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第1期
- data linkagemedicationpharmacovigilancepregnancyteratogen;
7.Community pharmacists’ knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia

机译：沙特阿拉伯Alahsa东部地区社区药剂师对药物不良反应的认识和看法以及对其报告的障碍
- 作者：Tahir M. Khan
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第2期
- adverse drug reactionbarrierscommunity pharmacistsknowledgeSaudi Arabia;
8.Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosis

机译：在药物诱导的磷脂中毒模型中尿中苯乙酰基甘氨酸水平升高与线粒体毒性相关
- 作者：Lucette Doessegger;Georg Schmitt;Barbara Lenz;Holger Fischer;G?tz Schlotterbeck;Elke-Astrid Atzpodien;Hans Senn;Laura Suter;Miklos Csato;Stefan Evers;Thomas Singer
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第3期
- biomarkerphospholipidosisurinary phenylacetylglycine;
9.Is tenofovir/emtricitabine teratogenic?

机译：替诺福韦/恩曲他滨有致畸作用吗？
- 作者：Murtala Jibril;Oluwaseun Egunsola
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第3期
- emtricitabinenevirapinepregnancyspina bifidatenofovirteratogenicity;
10.Fingolimod and cardiac risk: latest findings and clinical implications

机译：芬戈莫德和心脏风险：最新发现和临床意义
- 作者：Wendy S Vargas;Jai S Perumal
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第3期
- bradycardiacardiovascular risksdrug safetyfingolimod;
11.Calcium supplements and cardiovascular risk: 5 years on

机译：钙补充剂和心血管风险：5年以上
- 作者：Mark J. Bolland;Andrew Grey;Ian R. Reid
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第5期
- Calcium supplementscerebrovascular diseaseischemic heart diseasemyocardial infarctionosteoporosis;
12.Monitoring product safety in the postmarketing environment

机译：在售后环境中监视产品安全
- 作者：Robert G Sharrar;Gretchen S Dieck
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第5期
- pharmacovigilanceproduct safetysignal detection;
13.Preparing for safety issues following drug approval: pre-approval risk management considerations

机译：药品批准后准备安全问题：批准前的风险管理注意事项
- 作者：Gretchen S. Dieck;Robert G. Sharrar
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第5期
- pre-approvalpostapprovalrisk managementrisk mitigationsafety;
14.Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients

机译：老年住院患者抗胆碱能药物暴露量度与Barthel指数之间的相关性
- 作者：Clare V Bostock;Roy L Soiza;Arduino A Mangoni
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第6期
- AgedAnticholinergic Risk ScaleBarthel Indexcholinergic antagonistsDrug Burden Indexdrug toxicityfrail elderlymuscarinic antagonists;
15.Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma

机译：长效β受体激动剂和吸入性糖皮质激素对哮喘儿童和青少年的安全性
- 作者：Ying Xia;Christina M. L. Kelton;Liang Xue;Jeff J. Guo;Boyang Bian;Patricia R. Wigle
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第6期
- Drug safetygrowth suppressioninhaled corticosteroidslong-acting beta-agonistspediatric asthmaserious asthma exacerbations;
16.Risk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review

机译：慢性阻塞性肺疾病患者吸入抗胆碱药与急性尿retention留的风险：系统评价
- 作者：Yoon K. Loke;Sonal Singh
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第1期
- ipratropiumtiotropium urinary retention;
17.Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies

机译：设计重要吗？对观察研究中分析选择对效果估计的影响进行系统评估
- 作者：David Madigan;Patrick B. Ryan;Martijn Schuemie
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第2期
- analysishealthcare databasehealth outcomesstudy design;
18.Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications

机译：质子泵抑制剂与维生素和矿物质缺乏的风险：证据和临床意义
- 作者：Joel J. Heidelbaugh
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第3期
- antisecretory therapycalciumironmagnesiummineral deficiency proton pump inhibitor(s)vitamin B12vitamin Cvitamin deficiency;
19.A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital

机译：通过南印度一家教学医院的处方分析研究药物之间的相互作用
- 作者：Vijay Kulkarni;Swathi Swaroopa Bora;Sapineni Sirisha;Mohammed Saji;Siraj Sundaran
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第4期
- disease conditionsdrug–drug interactioninpatientsmanagementmechanismseverity;
20.Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies

机译：老年患者与毒品有关的跌倒：牵连的毒品，后果和可能的预防策略
- 作者：Marlies R. de Jong;Maarten Van der Elst;Klaas A. Hartholt
- 期刊名称：《Therapeutic advances in drug safety.》 | 2013年第4期
- accidental fallsageddrugsfallsrisk factors;
21.Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks

机译：联合激素避孕药：规定方式，依从性以及获益与风险
- 作者：Jan Brynhildsen
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第5期
- benefitscombined hormonal contraceptivescomplianceside effects;
22.Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain

机译：普瑞巴林：最新的安全性证据和对神经性疼痛管理的临床意义
- 作者：Cory Toth
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第1期
- adverse effectsanticonvulsant drugsepilepsyneuropathic painpregabalinreviewsafety;
23.Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review

机译：电子烟作为香烟替代品的安全性评估和风险评估：系统综述
- 作者：Konstantinos E. Farsalinos;Riccardo Polosa
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第2期
- electronic cigarettese-liquide-vaporharm reductionnicotinesafetytobacco;
24.Opioid formulations with sequestered naltrexone: a perspective review

机译：阿片类药物与隔离纳曲酮的应用：前景回顾
- 作者：Robert Taylor;Robert B. Raffa;Joseph V. Pergolizzi
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第3期
- abuse deterrentanalgesicchronic painopioidopioid risk management;
25.Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem

机译：抗菌素耐药性：与抗生素过度使用相关的风险以及减少该问题的措施
- 作者：Carl Llor;Lars Bjerrum
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第6期
- Antibiotic resistanceprimary carepoint-of-care testsrational use of antibioticsstrategies;
26.Safety of new oral anticoagulant drugs: a perspective

机译：新型口服抗凝药的安全性：一个观点
- 作者：Juan Antonio Vílchez;Pilar Gallego;Gregory Y.H. Lip
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第1期
- apixabanbleedingdabigatrannew oral anticoagulantsrivaroxaban;
27.Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-making

机译：安全使用抗血栓药预防心房颤动：考虑风险评估工具以支持决策
- 作者：Yishen Wang;Beata Bajorek
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第1期
- atrial fibrillationbleedingdecision makingrisk assessmentrisk versus benefitstrokestroke prevention;
28.Patients’ perspectives regarding long-term warfarin therapy and the potential transition to new oral anticoagulant therapy

机译：患者对长期华法林治疗的看法以及可能向新型口服抗凝治疗的过渡
- 作者：Gebler-Hughes Elizabeth S.;Kemp Linda;Bondlcolm J.
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第6期
- Warfarinoral anticoagulantsvitamin K antagonistsINRpatient preferences;
29.Safety of dipeptidyl peptidase 4 inhibitors: a perspective review

机译：二肽基肽酶4抑制剂的安全性：观点回顾
- 作者：Thomas Karagiannis;Panagiota Boura;Apostolos Tsapas
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第3期
- adverse effectsdrug safetydipeptidyl peptidase 4 inhibitorspancreatitistype 2 diabetes;
30.Varenicline and cardiovascular adverse events: a perspective review

机译：瓦伦尼克和心血管不良事件：观点回顾
- 作者：Yohalakshmi Chelladurai;Sonal Singh
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第4期
- adverse eventscardiovascularChampixChantixreviewvarenicline;
31.Quantification of active pharmaceutical ingredient and impurities in sildenafil citrate obtained from the Internet

机译：从互联网获得的柠檬酸西地那非中活性药物成分和杂质的定量
- 作者：Michael A. Veronin;Mohammad T. Nutan;Uday Krishna Reddy Dodla
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第5期
- drug importationdrug qualitydrug safetyInternet pharmacyquality assurance testingsildenafil citrateViagra?;
32.Medication-overuse headache: epidemiology, diagnosis and treatment

机译：药物滥用头痛：流行病学，诊断和治疗
- 作者：Espen Saxhaug Kristoffersen;Christofer Lundqvist
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第2期
- chronic headachedependencedrug safetymedication overusemigraine;
33.Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects

机译：妊娠期抗精神病药：对其母体和胎儿的影响
- 作者：Megan Galbally;Martien Snellen;Josephine Power
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第2期
- antipsychoticsbipolar disorderpregnancyschizophrenia;
34.Minimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycle

机译：尽量减少老年住院患者的抗胆碱药处方：完整的审核周期
- 作者：Hui Sian Tay;Roy L Soiza;Arduino A Mangoni
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第3期
- anticholinergic drugsdeprescribingdrug withdrawalelderlyprescribing;
35.Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors

机译：曲妥珠单抗辅助治疗相关的心血管毒性：患病率，患者特征和危险因素
- 作者：Adedayo A. Onitilo;Jessica M. Engel;Rachel V. Stankowski
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第4期
- breast cancerepidermal growth factordoxorubicinheart failureoxidative stresstrastuzumab;
36.Adverse effects of testosterone replacement therapy: an update on the evidence and controversy

机译：睾丸激素替代疗法的不良反应：证据和争议的最新进展
- 作者：Anthony Grech;John Breck;Joel Heidelbaugh
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第5期
- testosteroneadverse effectscardiovascular riskprostate-specific antigenmortality;
37.Dapagliflozin efficacy and safety: a perspective review

机译：达格列净疗效和安全性：观点回顾
- 作者：Sarah L. Anderson
- 期刊名称：《Therapeutic advances in drug safety.》 | 2014年第6期
- dapagliflozinhypoglycemic agentssodium-glucose transporter 2type 2 diabetes mellitus;
38.Risk of intracranial hypertension with intrauterine levonorgestrel

机译：宫内左炔诺孕酮引起颅内高压的风险
- 作者：Mahyar Etminan;Hao Luo;Paul Gustafson
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第3期
- cohort studydrug safetyintracranial hypertensionintrauterine levonorgestrel;
39.Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugs

机译：安全停止：停止使用抗血小板药物后的血小板活动回顾
- 作者：Isobel Ford
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第4期
- antiplatelet therapycessationclopidogrelP2Y12 inhibitorsplatelet activationrebound;
40.Anti-dementia medications: current prescriptions in clinical practice and new agents in progress

机译：抗痴呆药物：目前在临床实践中的处方和正在开发的新药物
- 作者：Florindo Stella;Márcia Radanovic;Paulo Renato Canineu;Vanessa J. R. de Paula;Orestes V. Forlenza
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第4期
- Alzheimer’s diseasecognitive impairmentdementiatreatmentpharmacology;
41.Routine deprescribing of chronic medications to combat polypharmacy

机译：常规开具慢性药物以对抗多药业
- 作者：Doron Garfinkel;Birkan Ilhan;Gulistan Bahat
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第6期
- Inappropriate-Medication-UsePolypharmacyIGRIMUPComorbidityDementiaFrailtyGeriatric-PalliativeLimited Life-expectancy;
42.Safety risks with investigational drugs: Pharmacy practices and perceptions in the veterans affairs health system

机译：研究用药物的安全风险：退伍军人事务卫生系统中的药学实践和认识
- 作者：Jennifer L. Cruz;Jamie N. Brown
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第3期
- clinical trialsinvestigational drugsmedication safetypharmacy practiceresearch pharmacist;
43.Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access

机译：纳洛酮对阿片类药物过量的安全性审查：新技术和扩大公众获取的实际考虑
- 作者：Daniel P. Wermeling
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第1期
- antidotedrug-delivery systemsnaloxoneopioidoverdose;
44.Abuse-deterrent formulations: transitioning the pharmaceutical market to improve public health and safety

机译：防止滥用的配方：转变药品市场以改善公共健康和安全
- 作者：Kyle Simon;Stacey L. Worthy;Michael C. Barnes;Benjamin Tarbell
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第2期
- abuse-deterrent formulationcontrolled substancepharmaceuticalsprescription drug abusesubstance abusesubstance use disorders;
45.Combination use of medicines from two classes of renin–angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function

机译：两种肾素-血管紧张素系统阻断剂的药物组合使用：高钾血症，低血压和肾功能受损的风险
- 作者：Raquel Esteras;Maria Vanessa Perez-Gomez;Laura Rodriguez-Osorio;Alberto Ortiz;Beatriz Fernandez-Fernandez
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第4期
- aldosteroneangiotensindiabetic nephropathydrug safetyheart failurepatiromerpotassiumRenin Angiotensin Aldosterone System (RAAS) blockadeRenin Angiotensin System (RAS) blockerszirconium cyclosilicate;
46.Safety and tolerability of 13-valent pneumococcal conjugate vaccine in healthy Chinese adults, children and infants

机译：13价肺炎球菌结合疫苗在健康的中国成年人，儿童和婴儿中的安全性和耐受性
- 作者：Fengcai Zhu;Yuemei Hu;Qi Liang;Mariano Young;Xin Zhou;Zhangjing Chen;John Z. Liang;William C. Gruber;Daniel A. Scott
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第6期
- 13-valent pneumococcal conjugate vaccinepneumococcal infectionssafety;
47.Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem

机译：全身性溶栓治疗肺栓塞的出血风险：问题范围
- 作者：Mitchell J. Daley;Manasa S. Murthy;Evan J. Peterson
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第2期
- alteplasebleeding hemorrhagepulmonary embolismthrombolytic therapy;
48.European Union pharmacovigilance capabilities: potential for the new legislation

机译：欧盟药物警戒能力：新法规的潜力
- 作者：John Joseph Borg;Amy Tanti;Dimitrios Kouvelas;Calin Lungu;Michal Pirozynski;Anthony Serracino-Inglott;George Aislaitner
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第4期
- adverse drug reactionsdrug safetyperiodic safety update reportspharmacovigilancePharmacovigilance and Risk Assessment Committeepost authorization safety studiesregulatory affairssignal detection;
49.Suvorexant in insomnia: efficacy, safety and place in therapy

机译：Suvorexant在失眠症中的疗效，安全性和治疗位置
- 作者：Danielle N. Rhyne;Sarah L. Anderson
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第5期
- dual orexin receptor antagonisthypocretininsomniasuvorexant;
50.New antiepileptic medication linked to blue discoloration of the skin and eyes

机译：新的抗癫痫药与皮肤和眼睛的蓝色变色有关
- 作者：Sarah Clark;Alexandra Antell;Kimberly Kaufman
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第1期
- antiepilepsy medicationezogabineseizureskin discoloration;
51.Published cases of adverse drug reactions: has the quality of reporting improved over time?

机译：已公布的药物不良反应案例：报告的质量是否随着时间的推移而有所改善？
- 作者：Sandra L. Kane-Gill;Pamela L. Smithburger;Evan A. Williams;Maria A. Felton;Nan Wang;Amy L. Seybert
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第2期
- adverse eventcase reportcase report guidelinesdrug-related side effects and adverse reactionsqualityreports;
52.Menopausal hormone therapy and breast cancer mortality: clinical implications

机译：更年期激素治疗与乳腺癌死亡率：临床意义
- 作者：Rowan T. Chlebowski;Garnet L. Anderson
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第2期
- breast cancerestrogen aloneestrogen plus progestinWomen’s Health Initiative;
53.A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone

机译：一项随机，交叉，安慰剂对照的临床试验，评估CRCDS Mini-Sim对佐匹克隆第二天残留效应的敏感性
- 作者：Arthur A. Simen;Cynthia Gargano;Jang-Ho Cha;Melissa Drexel;An Bautmans;Ingeborg Heirman;Tine Laethem;Thomas Hochadel;Lien Gheyle;Kim Bleys;Chan Beals;Aubrey Stoch;Gary G. Kay;Arie Struyk
- 期刊名称：《Therapeutic advances in drug safety.》 | 2015年第3期
- cognitiondriving simulationhypnoticsnext-day residual drug effectsstandard deviation of lane position;
54.Medication safety in neonatal care: a review of medication errors among neonates

机译：新生儿护理中的药物安全性：新生儿药物错误的综述
- 作者：Natalia Krzyzaniak;Beata Bajorek
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第3期
- medication errormedication safetyneonatesNICU;
55.Medication-overuse headache: a perspective review

机译：药物滥用头痛：观点回顾
- 作者：Maria Lurenda Westergaard;Signe Bruun Munksgaard;Lars Bendtsen;Rigmor H?jland Jensen
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第4期
- medication-overuse headachetreatmentepidemiologychronic headache;
56.Temporal trends in the use of antidiabetic medicines: a nationwide 9-year study in older people living in New Zealand

机译：使用抗糖尿病药的时间趋势：一项针对居住在新西兰的老年人的全国性9年研究
- 作者：Prasad S. Nishtala;Mohammed Saji Salahudeen
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第5期
- agedantidiabetic agentsdrug utilizationelderlyhypoglycemic agentsprevalencetrends;
57.Observed medical and surgical complications of prolonged barbiturate coma for refractory status epilepticus

机译：观察到巴比妥酸盐长期昏迷用于难治性癫痫持续状态的内科和外科并发症
- 作者：Christopher R. Newey;Dolora Wisco;Premkumar Nattanmai;Aarti Sarwal
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第5期
- cerebral atrophypentobarbital comarefractory status epilepticus;
58.Anticholinergic medication use and dementia: latest evidence and clinical implications

机译：抗胆碱药物的使用和痴呆：最新证据和临床意义
- 作者：Shelly L. Gray;Joseph T. Hanlon
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第5期
- agedantimuscarinicsdementia;
59.Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?

机译：药物引起的老年人跌倒：治疗性药物监测有作用吗？
- 作者：Klaas A. Hartholt;Matthijs L. Becker;Tischa J. M. van der Cammen
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第2期
- fallsgeriatric patientstherapeutic drug monitoring;
60.Safety of high-dose doripenem in adult patients with cystic fibrosis

机译：大剂量多瑞培南在成人囊性纤维化患者中的安全性
- 作者：Seth Strawbridge;Michael D. Nailor
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第3期
- adverse eventscystic fibrosisdoripenempharmacodynamicssafety;
61.Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats

机译：黑籽油对氟哌啶醇诱导的雄性大鼠神经元损伤中生态核苷酸酶，胆碱酯酶和胺能分解代谢酶的保护作用
- 作者：Jacob K. Akintunde;C. Abigail Irechukwu
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第4期
- bioenergeticsblack-seed oilcerebral damagehaloperidolneurotransmittersreversal;
62.Making rational choices about how best to support consumers’ use of medicines: a perspective review

机译：对如何最好地支持消费者使用药物做出理性选择：观点回顾
- 作者：Rebecca Ryan;Sophie Hill
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第4期
- consumer participationevidence-based medicinemedication adherencepolypharmacy;
63.Spontaneously reported haemorrhagic adverse events associated with rivaroxaban and dabigatran in Australia

机译：在澳大利亚自发报告与利伐沙班和达比加群相关的出血性不良事件
- 作者：Esa Y. H. Chen;Basia Diug;J. Simon Bell;Kevin P. Mc Namara;Michael J. Dooley;Carl M. Kirkpatrick;John J. McNeil;Gillian E. Caughey;Jenni Ilom?ki
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第1期
- adverse drug eventanticoagulantsdabigatrangastrointestinal haemorrhagehaemorrhagerivaroxaban;
64.Propofol-associated QTc prolongation

机译：异丙酚相关的QTc延长
- 作者：Michael J. Scalese;Holly R. Herring;R. Chris Rathbun;Grant H. Skrepnek;Toni L. Ripley
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第3期
- intensive carepropofolQTc prolongationsafety;
65.Revisiting the reported signal of acute pancreatitis with rasburicase: an object lesson in pharmacovigilance

机译：用糖苷酶复查急性胰腺炎的报道信号：药物警戒性的一个目标课
- 作者：Manfred Hauben;Eric Y. Hung
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第3期
- index publicationpancreatitispharmacovigilancerasburicasesignal detection;
66.Mirabegron in overactive bladder patients: efficacy review and update on drug safety

机译：Mirabegron在膀胱过度活动症患者中的疗效：药物安全性审查和更新
- 作者：Katherine Warren;Helena Burden;Paul Abrams
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第5期
- anticholinergicβ3 agonistmirabegronoveractive bladder;
67.Use of doripenem and risk of seizure and renal impairment in US hospitalized patients: a retrospective cohort study

机译：美国住院患者中多烯培南的使用以及癫痫和肾功能不全的风险：一项回顾性队列研究
- 作者：Scott Chavers;Glenn Magee;Dorothy Baumer;Helen Pai
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第2期
- cIAIcUTIdoripenemimipenemrenal impairmentseizure;
68.Predicting risk of adverse drug reactions in older adults

机译：预测老年人药物不良反应的风险
- 作者：Amanda Hanora Lavan;Paul Gallagher
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第1期
- adverse drug reactioninappropriate prescribingpolypharmacypredictive valuerisk assessment;
69.Factors associated with antidepressant use in residents with and without dementia in Australian aged care facilities

机译：澳大利亚老年护理机构中患有和不患有痴呆症的居民中与抗抑郁药使用相关的因素
- 作者：Henna Hiltunen;Edwin C. K. Tan;Jenni Ilom?ki;Sarah N. Hilmer;Renuka Visvanathan;Tina Emery;Leonie Robson;Mary J. Jones;Sirpa Hartikainen;J. Simon Bell
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第3期
- antidepressantsdementiadepressionhomes for the agedpain;
70.Nonmedical prescribing: where are we now?

机译：非处方药：我们现在在哪里？
- 作者：Louise C. Cope;Aseel S. Abuzour;Mary P. Tully
- 期刊名称：《Therapeutic advances in drug safety.》 | 2016年第4期
- nonmedical prescribingtraining programmehistoryimpactinfluences;
71.Tiotropium formulations and safety: a network meta-analysis

机译：噻托溴铵的配方与安全性：网络荟萃分析
- 作者：Mario Cazzola;Luigino Calzetta;Paola Rogliani;Maria Gabriella Matera
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第1期
- tiotropiumrespimat SMIhandihalersafetyCOPDmeta-analysis;
72.Response to treatment and adverse events associated with use of recombinant activated factor VII in children: a retrospective cohort study

机译：对儿童的治疗反应和与使用重组活化因子VII相关的不良事件的回顾性队列研究
- 作者：James D. Cooper;Arthur K. Ritchey
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第2期
- critical carehemorrhagepediatric hematologythrombosis;
73.Adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital

机译：三级教学医院因癌症化疗引起的药物不良反应
- 作者：Julie Birdie Wahlang;Purnima Devi Laishram;Dhriti Kumar Brahma;Chayna Sarkar;Joonmoni Lahon;Banylla Shisha Nongkynrih
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第2期
- adverse drug reactionscancer chemotherapypremedications;
74.Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events

机译：阿哌沙班，伴随药物和出血事件的自发报告
- 作者：Gillian E. Caughey;Lisa M. Kalisch Ellett;John D. Barratt;Sepehr Shakib
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第5期
- ApixabanNovel oral anticoagulantHaemorrhageAdverse eventSpontaneous reports;
75.Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence

机译：老年人使用质子泵抑制剂的不良反应：证据回顾
- 作者：Marina L. Maes;Danielle R. Fixen;Sunny Anne Linnebur
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第9期
- agedbone fracturesClostridium difficiledementiakidney diseaseslong-term adverse effectsosteoporosispneumoniaproton-pump inhibitorsvitamin B 12 deficiency;
76.Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence

机译：目标特异性口服抗凝剂在房颤中预防卒中的功效和安全性：真实证据
- 作者：Vincenzo Russo;Anna Rago;Riccardo Proietti;Federica Di Meo;Andrea Antonio Papa;Paolo Calabrò;Antonio D’Onofrio;Gerardo Nigro;Ahmed AlTurki
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第2期
- apixabanatrial fibrillationdabigatranefficacynovel oral anticoagulantreal liferivaroxabansafetystroke;
77.Adverse drug reactions in therapeutic hypothermia after cardiac arrest

机译：心脏骤停后治疗性体温过低的药物不良反应
- 作者：Robert Witcher;Amy L. Dzierba;Catherine Kim;Pamela L. Smithburger;Sandra L. Kane-Gill
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第3期
- adverse drug reactionscardiac arrestcritical caredrug-related side effects and adverse drug reactionsintensive carepharmacovigilancetherapeutic hypothermia;
78.Risk factors for adverse drug reactions in pediatric inpatients: a systematic review

机译：小儿住院患者药物不良反应的危险因素：系统评价
- 作者：Paulo Henrique Santos Andrade;Adriano da Silva Santos;Carlos Adriano Santos Souza;Iza Maria Fraga Lobo;Wellington Barros da Silva
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第6期
- childcohort studiesdrug-related side effects and adverse reactionshospitalsrisk factors;
79.Assessing and predicting drug-induced anticholinergic risks: an integrated computational approach

机译：评估和预测药物引起的抗胆碱能风险：综合计算方法
- 作者：Dong Xu;Heather D. Anderson;Aoxiang Tao;Katia L. Hannah;Sunny A. Linnebur;Robert J. Valuck;Vaughn L. Culbertson
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第11期
- adverse drug reactionsanticholinergic toxicityclinical toxicologybig datadrug safetybiomedical informatics;
80.Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem

机译：痴呆患者的综合药物治疗和不适当的药物使用：研究不足的问题
- 作者：Carole Parsons
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第1期
- adverse drug reactioncomorbiditydementiainappropriate medication useinappropriate prescribingpolypharmacy;
81.A practical approach to the pharmacological management of hypertension in older people

机译：老年人高血压药理管理的实用方法
- 作者：Nikesh Parekh;Amy Page;Khalid Ali;Kevin Davies;Chakravarthi Rajkumar
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第4期
- hypertensionmedicines optimizationmultimorbidityolder adults;
82.The impact of database restriction on pharmacovigilance signal detection of selected cancer therapies

机译：数据库限制对某些癌症疗法的药物警戒信号检测的影响
- 作者：Manfred Hauben;Eric Hung;Jennifer Wood;Amit Soitkar;Daniel Reshef
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第5期
- Safety SignalDisproportionality analysisDatabase restrictionOncologyPharmacovigilance;
83.Future perspectives on nonmedical prescribing

机译：非医学处方的未来观点
- 作者：Derek Stewart;Tesnime Jebara;Scott Cunningham;Ahmed Awaisu;Abdulrouf Pallivalapila;Katie MacLure
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第6期
- Nonmedical prescribingUmbrella reviewSystematic reviewEvaluation researchTheory;
84.Multidrug intolerance in the treatment of hypertension: result from an audit of a specialized hypertension service

机译：高血压治疗中的多药不耐受：对专业高血压服务的审核结果
- 作者：Basil N. Okeahialam
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第8期
- drughypertensionintolerancemultipleNigeriapoor control;
85.Gastrointestinal adverse effects of cyclin-dependent kinase 4 and 6 inhibitors in breast cancer patients: a systematic review and meta-analysis

机译：细胞周期蛋白依赖性激酶4和6抑制剂对乳腺癌患者的胃肠道不良反应：系统评价和荟萃分析
- 作者：Kyrillus S. Shohdy;Shaimaa Lasheen;Loay Kassem;Omar Abdel-Rahman
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第11期
- breast cancerCDK4/6 inhibitorsgastrointestinal toxicitypalbociclib;
86.A threshold trajectory was revealed by isolating the effects of hemoglobin rate of rise in anemia of chronic kidney disease

机译：通过隔离慢性肾脏病贫血中血红蛋白上升速率的影响揭示了阈值轨迹
- 作者：Gregory Fusco;Ali Hariri;Carlos Vallarino;Ajay Singh;Peter Yu;Lesley Wise
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第10期
- chronic kidney disease anemiaerythropoiesis stimulating agentshemoglobin rate of risehemoglobin reconstitutionhyporesponsivenessmanagement ofthreshold trajectory;
87.Screening for valve disease in patients with hyperprolactinaemia disorders prescribed cabergoline: a service evaluation and literature review

机译：卡麦角林高催乳素血症患者瓣膜疾病的筛查：服务评估和文献复习
- 作者：David Gamble;Rachel Fairley;Roderick Harvey;Colin Farman;Nathan Cantley;Stephen J. Leslie
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第7期
- cabergolinecardiac valve diseaseechocardiography surveillance;
88.A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionality

机译：一个数学框架，用于量化与不成比例度量的置信区间相关的掩盖效应
- 作者：Fran?ois Maignen;Manfred Hauben;Jean-Michel Dogné
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第7期
- adverse drug reactions reporting systemsmaskingpharmacovigilancepostmarketingproduct surveillancesignalsignal detection;
89.Potential drug–drug interactions with direct oral anticoagulants in elderly hospitalized patients

机译：老年住院患者与直接口服抗凝药的潜在药物相互作用
- 作者：Heather L. Forbes;Thomas M. Polasek
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第10期
- bleedingdirect oral anticoagulantsDOACsdrug–drug interactionsselective serotonin reuptake inhibitors;
90.An exploratory factor analysis of the spontaneous reporting of severe cutaneous adverse reactions

机译：自发报告严重皮肤不良反应的探索性因素分析
- 作者：Manfred Hauben;Eric Hung;Wen-Yaw Hsieh
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第1期
- Factor analysisCutaneous adverse drug reactionsSponanteous reporting;
91.Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes

机译：注意缺陷多动障碍药物的使用：处方，安全性方面和结果涉及的因素
- 作者：Jose Martinez-Raga;Amparo Ferreros;Carlos Knecht;Raquel de Alvaro;Eloisa Carabal
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第3期
- attention-deficit hyperactivity disordercardiovascular eventsdrug diversionpharmacotherapysystematic review;
92.Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications

机译：非甾体类抗炎药和环氧合酶2抑制剂对心血管和脑血管的危险：最新证据和临床意义
- 作者：Andrea Fanelli;Daniela Ghisi;Pierangelo Lora Aprile;Francesco Lapi
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第6期
- nonsteroidal anti-inflammatory drugscyclooxygenase 2 inhibitorscardiovascular riskcerebrovascular riskparacetamol;
93.Non-medical prescribing in New Zealand: an overview of prescribing rights, service delivery models and training

机译：新西兰的非医疗处方：处方权利，服务提供模式和培训的概述
- 作者：Rakhee Raghunandan;June Tordoff;Alesha Smith
- 期刊名称：《Therapeutic advances in drug safety.》 | 2017年第11期
- educationhealthcare policynonmedical prescribingpharmacist prescriberprescribing competencies;
94.Likelihood of reporting medication errors in hospitalized children: a survey of nurses and physicians

机译：报告住院儿童用药错误的可能性：对护士和医生的调查
- 作者：Rikke Mie Rishoej;Jesper Hallas;Lene Juel Kjeldsen;Henrik Thybo Christesen;Anna Birna Almarsdóttir
- 期刊名称：《Therapeutic advances in drug safety.》 | 2018年第3期
- incident reportingpaediatricspatient safetymedication errors;
95.Spontaneously reported adverse drug events related to tapentadol and oxycodonealoxone in Australia

机译：在澳大利亚自发报告与他喷他多和羟考酮/纳洛酮有关的不良药物事件
- 作者：Carmen Abeyaratne;Samanta Lalic;J. Simon Bell;Jenni Ilom?ki
- 期刊名称：《Therapeutic advances in drug safety.》 | 2018年第4期
- adverse drug eventsopioidoxycodone-naloxoneserotonin syndromesubstance withdrawal syndrometapentadol;
96.Managing acute pain in patients who report lactose intolerance: the safety of an old excipient re-examined

机译：报告乳糖不耐症的患者的急性疼痛处理：旧辅料的安全性重新检查
- 作者：Deanna Mill;Jessica Dawson;Jacinta Lee Johnson
- 期刊名称：《Therapeutic advances in drug safety.》 | 2018年第5期
- acute painanalgesicscodeineexcipientlactase deficiencylactose intolerance;
97.Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study

机译：使用应用内调查众包sugammadex不良事件发生率：一项观察性研究的可行性评估
- 作者：Craig S. Jabaley;Francis A. Wolf;Grant C. Lynde;Vikas N. O’Reilly-Shah
- 期刊名称：《Therapeutic advances in drug safety.》 | 2018年第7期
- anaphylaxiscrowdsourcingmHealthsugammadex;
98.Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research

机译：智障老年人的药物使用和可能不适当的处方：一个被忽视的研究领域
- 作者：Maire O’Dwyer;Philip McCallion;Mary McCarron;Martin Henman
- 期刊名称：《Therapeutic advances in drug safety.》 | 2018年第9期
- intellectual disabilitypolypharmacyolder adultspotentially inappropriate prescribingpsychotropics;
99.Dosing challenges with direct oral anticoagulants in the elderly: a retrospective analysis

机译：老年人直接口服抗凝药的剂量挑战：回顾性分析
- 作者：Joseph P. Fava;Katelyn M. Starr;David Ratz;Jennifer L. Clemente
- 期刊名称：《Therapeutic advances in drug safety.》 | 2018年第8期
- anticoagulantatrial fibrillationdosingelderly;
100.Significant drug–drug interaction between warfarin and nafcillin

机译：华法林与萘夫西林之间显着的药物相互作用
- 作者：Cynthia A. King;Kathleen M. Babcock;Rhianna J. Godios;Benjamin S. King
- 期刊名称：《Therapeutic advances in drug safety.》 | 2018年第11期
- warfarinnafcillindrug interactionsCYP 3A4 inductionsubtherapeutic INR;

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号